O-glycosylation delays the clearance of human IGF-binding protein-6 from the circulation

European Journal of Endocrinology

Volumn 142, Issue 5, 2000, Pages 512-516

  Marinaro, Joe A ^a   Casley, David J ^a   Bach, Leon A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 6;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCULATION; GLYCOSYLATION; HALF LIFE TIME; KINETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; RAT; TISSUE SPECIFICITY;

EID: 0034038611     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1420512     Document Type: Article

References (31)

1. Jones JI & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1945 16 3-34.
2. Bach LA & Rechler MM. Insulin-like growth factor binding proteins. Diabetes Reviews 1995 3 38-61.
3. Baxter RC, Martin JL & Beniac VA. High molecular weight insulin-like growth factor binding protein complex. Journal of Biological Chemistry 1989 264 11843-11848.
4. Twigg SM & Baxter RC. Insulin-like growth factor (IGF)-binding protein 5 forms an alternative ternary complex with IGFs and the acid-labile subunit. Journal of Biological Chemistry 1998 273 6074-6079.
5. Rajaram S, Baylink DJ & Mohan S. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrine Reviews 1997 18 801-831.
6. Guler HR Zapf J, Schmid C & Froesch ER. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinologica 1989 121 753-758.
7. Bach LA. Insulin-like growth factor binding protein-6: the 'forgotten' binding protein? Hormone and Metabolic Research 1999 31 226-234.
8. Gabbitas B & Canalis E. Retinoic acid stimulates the transcription of insulin-like growth factor binding protein-6 in skeletal cells. Journal of Cell Physiology 1996 169 15-22.
9. Toretsky JA & Helman LJ. Involvement of IGF-II in human cancer. Journal of Endocrinology 1996 149 367-372.
10. Bach LA, Thotakura NR & Rechler MM. Human insulin-like growth factor binding protein-6 is O-glycosylated. Biochemical and Biophysical Research Communications 1992 186 301-307.
11. Neumann GM, Marinaro JA & Bach LA. Identification of O-glycosylation sites and partial characterization of carbohydrate structure and disulfide linkages of human insulin-like growth factor binding protein-6. Biochemistry 1998 37 6572-6585.
12. Cole ES, Nichols EH, Poisson L, Harnois ML & Livingston DJ. In vivo clearance of tissue plasminogen activator: the complex role of sites of glycosylation and level of sialylation. Fibrinolysis 199 37 15-22.
13. Briggs DW, Fisher JW & George WJ. Hepatic clearance of intact and desialylated erythropoietin. American Journal of Physiology 1974 227 1385-1388.
14. Burgon PG, Stanton PG & Robertson DM. In vivo bioactivities and clearance patterns of highly purified human luteinizing hormone isoforms. Endocrinology 1996 137 4827-4836.
15. Marinaro JA, Jamieson GP, Hogarth PM & Bach LA. Differential dissociation kinetics explain the binding preference of insulin-like growth factor binding protein-6 for insulin-like growth factor-II over insulin-like growth factor-I. FEBS Letters 1999 450 240-244.
16. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993 3 97-130.
17. Baenziger JU. Glycosylation: to what end for the glycoprotein hormones? Endocrinology 1996 137 1520-1522.
18. Jentoft N. Why are proteins O-glycosylated? Trends in Biochemical Sciences 1990 15 291-294.
19. Morell, AG, Gregoriadis G, Scheinberg IH, Hickman J & Ashwell G. The role of sialic acid in determining the survival of glycoproteins in the circulation. Journal of Biological Chemistry 1971 246 1461-1467.
20. Wasley LC, Timony G, Murtha P, Stoudemire J, Dorner AJ, Caro J et al. The importance of N-and O-linked oligosaccharides for the biosynthesis and in vitro and in vivo biologic activities of erythropoietin. Blood 1991 77 2624-2652.
21. Larsen, GR, Metzger M, Henson K, Blue Y & Horgan P Pharmacokinetics and distribution analysis of variant forms of tissue-type plasminogen activator with prolonged clearance in rat. Blood 1989 73 1842-1850.
22. Holst J, Lindblad B, Westerlund G, Bregengaard C, Ezban M. Ostergaard PB et al. Pharmacokinetics and delayed experimental anti-thrombotic effect of two domain non-glycosylated tissue factor pathway inhibitor. Thrombosis Research 1996 81 461-470.
23. Bishop LA, Nguyen TV & Schofleld PR. Both of the beta-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potency. Endocrinology 1995 136 2635-2640.
24. Young SC, Miles MV & Clemmons DR. Determination of the pharmacokinetic profiles of insulin-like growth factor binding proteins-1 and -2 in rats. Endocrinology 1992 131 1867-1873.
25. Sommer A, Spratt SK, Tatsuno GP, Tressel T, Lee R & Maack CA. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Growth Regulation 1993 3 46-49.
26. Firth SM & Baxter RC. The role of glycosylation in the action of IGFBP-3. Progress in Growth Factor Research 1995 6 223-229.
27. Bar RS, Clemmons DR, Boes M, Busby WH Jr, Booth BA, Dake BL et al. Transcapiliary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology 1990 127 1078-1086.
28. Boes M, Booth BA, Sandra A, Dake BL, Bergold A & Bar RS. Insulin-like growth factor binding protein (IGFBP)4 accounts for the connective tissue distribution of endothelial cell IGFBPs perfused through the isolated heart. Endocrinology 1992 131 327-330.
29. Sandra A, Boes M, Dake BL, Stokes JB & Bar RS. Infused IGF-I/ IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney. American Journal of Physiology 1998 275 E32-E37.
30. Arany E, Zabel P, Freeman D & Hill DJ. Elimination of radiolabelled recombinant human insulin-like growth factor binding protein-3 from the circulation, and its distribution amongst organs and tissues in adult male rats. Regulatory Peptides 1993 48 133-143.
31. Regoeczi E. Iodine Labeled Plasma Proteins. Boca Raton, FL, USA: CRC Press, 1987.